Home

Helen Torley

CIK 1528185 · PRESIDENT AND CEO · last filed 2026-09-11

Helen Torley is a PRESIDENT AND CEO who has filed 144 SEC Form 4 insider transactions across 5 companies since 2011. The most recent filing, for HALO, was dated Sep 11, 2026. Across all open-market trades the lifetime net is −$100.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $89.5M across reported positions. 8 SEC filings were submitted jointly with QUEST DIAGNOSTICS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$89.55M

Companies

5

Total Filings

144

Lifetime Open-Market Net

-$100.54M

Filer Profile

Reported Address
12390 EL CAMINO REAL
SAN DIEGO, CA 92130
Related Filers
QUEST DIAGNOSTICS INC — 8 joint filings, latest 2021-05-25
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HALO PRESIDENT AND CEO 773,192 $113.90 $88.07M -$12.87M 3 2026-09-11
HTI PRESIDENT AND CEO 767,780 — — -$83.25M 89 2026-06-03
DGX Director 6,260 $236.32 $1.48M $0 7 2021-05-25
Relypsa Inc (RLYP) Delisted Director 0 — — -$19.6K 5 2016-09-02
ONYX PHARMACEUTICALS INC (ONXX) Delisted EVP, Chief Commercial Officer 35,911 — — -$4.40M 14 2013-09-05

Recent Filings

144 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-11 HALO Mixed — -$5.33M EDGAR
2026-08-19 HALO Mixed — -$5.17M EDGAR
2026-08-17 HALO Notice (144) −240,000 -$23.68M EDGAR
2026-07-09 HALO Mixed — -$130.2K EDGAR
2026-06-03 HTI Mixed — -$2.77M EDGAR
2026-05-13 HTI Mixed — -$2.83M EDGAR
2026-05-11 HALO Notice (144) −101,923 -$6.54M EDGAR
2026-04-07 HTI Mixed — -$514.3K EDGAR
2026-04-02 HTI Mixed — -$2.11M EDGAR
2026-03-04 HTI Mixed — -$2.87M EDGAR
Showing 1–10 of 144
Page 1 of 15
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.